"Evidence is weak" for cold treatment with echinacea

by Stephanie Stephens
“Evidence is weak

(Medical Xpress)—For people seeking a natural treatment for the common cold, some preparations containing the plant Echinacea work better than nothing, yet "evidence is weak," finds a new report from The Cochrane Library. The evidence review revealed no significant reductions in preventing illness, but didn't rule out "small preventive effects."

The six authors conducted reviews on this subject in 1998, 2006 and 2008 and wanted to do an update to include several new trials conducted since then. "We've been doing this for so long and are very familiar with past research—which has been mixed from the very beginning," said author Bruce Barrett, M.D., Ph.D. in the department of family medicine at the University of Wisconsin in Madison.

The research team reviewed 24 to determine whether Echinacea was a safe and effective cold prevention and treatment. Trials included 4631 participants and 33 preparations, along with placebo. Echinacea products studied in these trials varied widely according to characteristics of three different plant species, the part of the plant used and method of manufacturing.

People who get colds spend $8 billion annually on pharmaceutical products, including supplements such as Echinacea, Barrett noted. The authors' meta-analyses suggest that at least some Echinacea preparations may reduce the relative risk of catching a cold by 10 to 20 percent, a small effect of unclear clinical significance. The most important recommendation from the review for consumers and clinicians is a caution that Echinacea products differ greatly and that the overwhelming majority of these products have not been tested in .

Barrett added that "it looks like taking Echinacea may reduce the incidence of colds. For those who take it as a treatment, some of the trials report real effects—but many do not. Bottom line: Echinacea may have small preventive or treatment effects, but the evidence is mixed."

"The paper does support the safety and efficacy of Echinacea in treating colds and highlights the main issue of standardizing herbal medicines," commented Ron Eccles, Ph.D., director of the Common Cold Centre & Healthcare Clinical Trials at Cardiff University's School of Biosciences in Wales.

More information: Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. "Echinacea for preventing and treating the common cold." Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD000530. DOI: 10.1002/14651858.CD000530.pub3.

add to favorites email to friend print save as pdf

Related Stories

Vitamin C is beneficial against the common cold

Feb 13, 2013

(Medical Xpress)—According to an updated Cochrane review on vitamin C and the common cold, vitamin C seems to be particularly beneficial for people under heavy physical stress.

Exploring Echinacea's enigmatic origins

Mar 05, 2010

An Agricultural Research Service (ARS) scientist is helping to sort through the jumbled genetics of Echinacea, the coneflower known for its blossoms--and its potential for treating infections, inflammation, and other human ...

Recommended for you

Determine patient preferences by means of conjoint analysis

21 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments